One of the major problems in prostate cancer （PCa） diagnosis and treatment relates to the difficulty in discriminating between slowgrowing, indolent cancers and more aggress- ive tumors with a lethal outcome. There...One of the major problems in prostate cancer （PCa） diagnosis and treatment relates to the difficulty in discriminating between slowgrowing, indolent cancers and more aggress- ive tumors with a lethal outcome. Therefore, much research has been devoted to the identification of reliable biomarkers that predict disease progression and treatment outcome.展开更多
文摘One of the major problems in prostate cancer （PCa） diagnosis and treatment relates to the difficulty in discriminating between slowgrowing, indolent cancers and more aggress- ive tumors with a lethal outcome. Therefore, much research has been devoted to the identification of reliable biomarkers that predict disease progression and treatment outcome.
